Lv4
578 积分 2025-03-04 加入
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer
3天前
已完结
Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis
4天前
已完结
Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis
4天前
已完结
Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis
12天前
已完结
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study
1个月前
已完结
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
2个月前
已完结
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer A Phase 2 Clinical Trial
2个月前
已完结
Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study
2个月前
已完结
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
2个月前
已完结
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study
2个月前
已完结
皖公网安备34019202002308
